Concepedia

Yan Lou

YL

Statistics

Publications

25

Citations

1.6K

H-Index

17

Active since

1994

Affiliations

La Roche College(Current)

Heilongjiang Bayi Agricultural University

Roche (Switzerland)

University of Illinois Chicago

Baxter (United States)

Yan Lou is an author at La Roche College specializing in pharmacology, tyrosine kinase inhibitors, and life sciences.

ORCID

Publications per year

1994–2024

25

Publications

25

A New Chiral Rh(II) Catalyst for Enantioselective [2 + 1]-Cycloaddition. Mechanistic Implications and Applications

Yan Lou, Manabu Horikawa, R.A. Kloster et al. · Journal of the American Chemical Society · 2004 · 212 citations

, , +15

Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction

K.R. Simonetta, Joshua P. Taygerly, Kathleen Boyle et al. · Nature Communications · 2019 · 209 citations · Full text

, , +13

Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders

David Goldstein, A. Kuglstatter, Yan Lou et al. · Journal of Medicinal Chemistry · 2009 · 183 citations · Full text

, , +6

RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents

Daigen Xu, Yong Kim, Jennifer Postelnek et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 141 citations

, , +17

Catalysis of Enantioselective [2+1]-Cycloaddition Reactions of Ethyl Diazoacetate and Terminal Acetylenes Using Mixed-Ligand Complexes of the Series Rh<sub>2</sub>(RCO<sub>2</sub>)<i><sub>n</sub></i> (L*<sub>4</sub><sub>-</sub><i><sub>n</sub></i>). Stereochemical Heuristics for Ligand Exchange and Catalyst Synthesis

Yan Lou, Travis Remarchuk, E. J. Corey · Journal of the American Chemical Society · 2005 · 126 citations

, , +16

1–5 of 25